Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Patching Retinal Breaks With Healaflow in 27G Vitrectomy for the Treatment of Rhegmatogenous Retinal Detachment

NCT03542162 is registered in ClinicalTrials.gov with Tianjin Medical University Eye Hospital as lead sponsor.

NCT NCT03542162
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03542162 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Patching Retinal Breaks With Healaflow in 27G Vitrectomy for the Treatment of Rhegmatogenous Retinal Detachment
Lead sponsor
Tianjin Medical University Eye Hospital
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2017
Completion date
December 1, 2018
Enrollment
37 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

rhegmatogenous retinal detachment